Drug Enforcement Administration, Justice.
Notice of application.
Noramco Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 21, 2020. Such persons may also file a written request Start Printed Page 67375for a hearing on the application on or before December 21, 2020.
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Start Supplemental Information
In accordance with 21 CFR 1301.33(a), this is notice that on October 6, 2020, Noramco Inc. 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):
|Controlled substance||Drug code||Schedule|
|Opium fluid extract||9620||II|
The company plans to manufacture the listed controlled substances as an Active Pharmaceutical Ingredient (API) for supply to its customers. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration.
End Supplemental Information
William T. McDermott,
[FR Doc. 2020-23396 Filed 10-21-20; 8:45 am]
BILLING CODE P